AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
18.59
-0.28 (-1.48%)
Feb 21, 2025, 4:00 PM EST - Market closed
AnaptysBio Analyst Ratings
Total Analysts
12
Consensus Rating
Buy
Price Target
$41.20
Upside
+121.62%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $40 → $51 | Buy | Maintains | $40 → $51 | +174.34% | Feb 13, 2025 |
| Wedbush | Wedbush | Buy Maintains $40 | Buy | Maintains | $40 | +115.17% | Feb 7, 2025 |
| Wolfe Research | Wolfe Research | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Feb 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $19 | Hold | Reiterates | $19 | +2.21% | Feb 4, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $66 → $36 | Buy | Maintains | $66 → $36 | +93.65% | Dec 19, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $30 → $20 | Hold | Maintains | $30 → $20 | +7.58% | Dec 18, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $56 → $40 | Buy | Maintains | $56 → $40 | +115.17% | Dec 12, 2024 |
| Guggenheim | Guggenheim | Strong Buy Maintains $90 → $36 | Strong Buy | Maintains | $90 → $36 | +93.65% | Dec 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 11, 2024 |
| BTIG | BTIG | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 2, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $75 → $66 | Buy | Maintains | $75 → $66 | +255.03% | Nov 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $55 → $52 | Strong Buy | Maintains | $55 → $52 | +179.72% | Nov 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $55 | Strong Buy | Reiterates | $55 | +195.86% | Oct 31, 2024 |
| UBS | UBS | Hold Maintains $23 → $33 | Hold | Maintains | $23 → $33 | +77.51% | Oct 30, 2024 |
| Guggenheim | Guggenheim | Strong Buy Maintains $75 → $90 | Strong Buy | Maintains | $75 → $90 | +384.13% | Oct 21, 2024 |
| Wedbush | Wedbush | Buy Reiterates $42 | Buy | Reiterates | $42 | +125.93% | Sep 26, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.